2 Interesting Developments on 2 Major Marijuana Producers This Month

Find out the two interesting developments from Aphria Inc. (TSX:APH) and Aurora Cannabis Inc. (TSXV:ACB) in the marijuana space.

| More on:

The local marijuana industry is still in a fast-paced development mode as the incumbent competitors vie for market share, both on the consumer market and on the investor market front. There have been two interesting developments with Aurora Cannabis Inc. (TSXV:ACB) and Aphria Inc. (TSX:APH).

Aurora Cannabis Inc.

The local marijuana industry’s most aggressive kid — Aurora Cannabis — has finally come of age, way faster than its big brothers.

Aurora has just announced that it’s finally graduating from the junior TSX Venture exchange (TSXV) to the senior TSX. The company has received conditional approval from the Toronto Stock Exchange to list its shares on the main TSX.

With this graduation, Aurora seeks to attract the more senior and savvy investors, especially institutional investors and money managers whose mandates and internal policies only allow them to invest in companies listed on the senior TSX.

The date for this graduation has not been given as of yet though, so the market may be given a clearer message on the issue in a short while. The CEO, however, says the final approval is “imminent.”

Judging from history, Aphria announced its conditional graduation approval from the TSXV on February 6, 2017, and finally graduated on March 22, while Canopy Growth Corp. announced the granting of its conditional approval on June 6, 2016, and finally graduated on July 26 the same year.

Therefore, by simple inference, Aurora shares could be trading on the major TSX by late next month.

Institutional investors are believed to bring better price discovery on a stock and somehow bring some price stability on a ticker, but when they decide to exit, the stock may take a deeper plunge.

Aphria Inc.

Aphria seems to be increasing its pace on the United States-focused international expansion program announced April 4, 2017.

The company may have applied for a cannabis-growing licence in the newly legalized Ohio State market.

As one popular cannabis analyst, Alan Brochstein, CFA, has verified, Aphria has gone into a partnership with the well-known Schottenstein family of Ohio, and the two are reported to have applied for a Level I growing licence.

The Ohio State has 12 licences for grabs in two categories: Level I and Level II.

The data released by The Ohio Department of Commerce about applicants has Schottenstein Aphria LLC as one of the 109 Level I licence applicants.

Level I applicants will be allowed to grow from an initially capped capacity of 25,000-square-feet facility, while the smaller Level II applicants will have their production confined to a 3,000-square-feet growing space.

If the Schottenstein-Aphria partnership manages to grab one of the 12 licences in the applied category, then Ohio will become the third U.S state in which the marijuana producer will have a presence.

Curently, Aphria has operations in Arizona through its 18.5% stake in Copperstate Farms LLC, and in Florida through its strategic investment in Liberty Health Sciences Inc., set to trade a “Aphria USA.”

Foolish bottom line

The above developments could be good news for investors in the two concerned marijuana producers, especially for Aphria shareholders if the company manages to grab a licence. Aurora investors may continue to see more institutional investors among them.

Institutional investors are big elephants; they could bring joy to shareholders as the stock price will track intrinsic value more closely, but should there be a wrong move from Aurora management, the resultant stock price plunge could be magnified as the elephants move out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any stocks mentioned.

More on Investing

Stock analysts were once excited about construction company Aecon as an investment.

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Specialty Brands faces higher raw materials costs.
Dividend Stocks

What’s Next for Premium Brands Stock?

Shares of the specialty food production and distribution company have fallen about 25% since last October.

Read more »

Double exposure of a businessman and stairs - Business Success Concept
Dividend Stocks

2 Interesting Buys in Any Market

Here are two intriguing buys in any market climate that offer defensive appeal as well as growth and income earning…

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Should You Buy Bank Stocks Now?

Canadian bank stocks are getting cheap. Is this the right time to buy?

Read more »

stock data
Stocks for Beginners

2 Reliable Stocks Beginners Can Buy Amid the Market Selloff

As the broader market turmoil continues, new investors can buy these two reliable dividend stocks to get good returns on…

Read more »

Biotech stocks can be good yet risky investments.

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

Dividend Stocks

TFSA Investors: 3 TSX Stocks for Tax-Free Passive Income

These Canadian corporations have strong visibility over future earnings and dividend payouts.

Read more »

Piggy bank next to a financial report

Do You Have Cash Sitting in Your TFSA? Now Is a Great Time to Buy Stocks

If you have cash in your TFSA that you're looking to invest, now is a great time to buy high-quality…

Read more »